Cotswold Way Ultra Challenge 2024
Is 2024 the year that you join #TeamRetinaUK & take on the Cotswold Way Ultra Challenge?
Search
Search results
Peak District Ultra Challenge 2024
Is 2024 the year that you join #TeamRetinaUK & take on the Peak District Ultra Challenge?
North Downs 50 Ultra Challenge 2024
Is 2024 the year that you join #TeamRetinaUK & take on the North Downs 50 Ultra Challenge?
South West 50 Ultra Challenge 2024
Is 2024 the year that you join #TeamRetinaUK & take on the South West 50 Ultra Challenge?
Sahara Desert Trek 2025
Could you take on an adventure of a lifetime for Retina UK and take part in the Sahara Desert Trek in November 2025?
Phase 3 clinical trial has been given approval by FDA
The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).
Optogenetics
The BBC covered a story on Monday 24 May about optogenetics partially restoring the sight of a man living with retinitis pigmentosa in France.
Encouraging results from ProQR USH2A clinical trial
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
Let’s talk about tech
As people living with sight loss we are constantly looking for solutions to make our lives easier without too much effort or cost writes Jonathan Abro.
Stem cells
Stem cells are a special type of cell, which under the right conditions can be encouraged to grow into any other type of cell in the body, including retinal cells (rods, cones and retinal pigment epithelial cells).